Anson Funds Management LP - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Anson Funds Management LP ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2017$446,000
-68.0%
1,237,957
-48.5%
0.30%
-31.7%
Q2 2017$1,394,000
-0.4%
2,403,553
+112.2%
0.44%
+114.1%
Q1 2016$1,399,0001,132,7370.21%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
Prospera Financial Services Inc 176,100$287,0000.05%
RFG Advisory, LLC 40,000$65,0000.05%
Acrospire Investment Management LLC 16,551$29,0000.02%
HighTower Advisors, LLC 1,047,731$1,854,0000.02%
B. Riley Wealth Advisors, Inc. 25,958$46,0000.01%
EXENCIAL WEALTH ADVISORS, LLC 11,900$19,0000.01%
THOMPSON DAVIS & CO., INC. 3,000$5,0000.01%
LBA Wealth Management, LLC 8,000$14,0000.01%
INGALLS & SNYDER LLC 20,739$37,0000.00%
Vantage Investment Advisors, LLC 1,150$2,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders